State Key Laboratory of Resource Insects, Southwest University, Chongqing, China.
Advanced Research Center in Brain Diseases, Jinfeng Laboratory, Chongqing, China.
Neuro Oncol. 2023 Nov 2;25(11):2015-2027. doi: 10.1093/neuonc/noad111.
Nonstructural maintenance of chromatin condensin I complex subunit G (NCAPG), also known as non-structural maintenance of chromosomes condensin I complex subunit G, is mitosis-related protein that widely existed in eukaryotic cells. Increasing evidence has demonstrated that aberrant NCAPG expression was strongly associated with various tumors. However, little is known about the function and mechanism of NCAPG in glioblastoma (GBM).
The expression and prognostic value of NCAPG were detected in the clinical databases and tumor samples. The function effects of NCAPG downregulation or overexpression were evaluated in GBM cell proliferation, migration, invasion, and self-renewal in vitro and in tumor growth in vivo. The molecular mechanism of NCAPG was researched.
We identified that NCAPG was upregulated in GBM and associated with poor prognosis. Loss of NCAPG suppressed the progression of GBM cells in vitro and prolonged survival in mouse models of GBM in vivo. Mechanistically, we revealed that NCAPG positively regulated E2F transcription factor 1 (E2F1) pathway activity. By directly interacting with Poly (ADP-ribose) polymerase 1, a co-activator of E2F1, and facilitating the PARP1-E2F1 interaction to activate E2F1 target gene expression. Intriguingly, we also discovered that NCAPG functioned as a downstream target of E2F1, which was proved by the ChIP and Dual-Luciferase results. Comprehensive data mining and immunocytochemistry analysis revealed that NCAPG expression was positively associated with the PARP1/E2F1 signaling axis.
Our findings indicate that NCAPG promotes GBM progression by facilitating PARP1-mediated E2F1 transactivation, suggesting that NCAPG is a potential target for anticancer therapy.
非结构维持染色质凝聚素 I 复合物亚基 G(NCAPG),也称为非结构维持染色体凝聚素 I 复合物亚基 G,是一种与有丝分裂相关的蛋白,广泛存在于真核细胞中。越来越多的证据表明,异常的 NCAPG 表达与各种肿瘤密切相关。然而,关于 NCAPG 在神经胶质瘤(GBM)中的功能和机制知之甚少。
在临床数据库和肿瘤样本中检测 NCAPG 的表达和预后价值。在体外评估 NCAPG 下调或过表达对 GBM 细胞增殖、迁移、侵袭和自我更新的功能影响,并在体内评估对 GBM 肿瘤生长的影响。研究 NCAPG 的分子机制。
我们发现 NCAPG 在 GBM 中上调,并与不良预后相关。NCAPG 缺失抑制了 GBM 细胞在体外的进展,并延长了体内 GBM 模型小鼠的存活时间。机制上,我们揭示了 NCAPG 正向调控 E2F 转录因子 1(E2F1)通路活性。通过直接与 E2F1 的共激活子多聚(ADP-核糖)聚合酶 1(PARP1)相互作用,并促进 PARP1-E2F1 相互作用以激活 E2F1 靶基因表达。有趣的是,我们还发现 NCAPG 作为 E2F1 的下游靶标发挥作用,这一点通过 ChIP 和双荧光素酶结果得到了证实。综合数据挖掘和免疫细胞化学分析表明,NCAPG 表达与 PARP1/E2F1 信号轴呈正相关。
我们的研究结果表明,NCAPG 通过促进 PARP1 介导的 E2F1 反式激活促进 GBM 进展,表明 NCAPG 是一种潜在的抗癌治疗靶点。